FORM 3A - Director/Chief Executive Notice - Interests in Shares of Listed Corporation
 
Form Serial Number: DA20251010E00586
1. Date of relevant event: 06/10/2025
(dd/mm/yyyy)
2. Date when director became aware of the relevant event/ interest in the shares (if later):
(dd/mm/yyyy)
3. Stock code: 00673
4. Name of listed corporation: China Health Group Ltd. 
5. Class of shares: Ordinary Shares 
6. Number of issued shares in class: 1,339,138,191
7. Name of director (English) as printed on HKID Card/Passport:
(Surname) WANG
(Other names) JINGMING
10. Name of director (Chinese): 王景明 
11. Chinese Character Code as printed on HKID Card:
 
24. Details of relevant event:
  Brief description of relevant event Capacity in which shares were/are held Number of shares bought/sold or involved Currency of transaction On Exchange Off Exchange
Before relevant event After relevant event Highest price (per share) Average price (per share) Average consideration (per share) Consideration code
Long position 
1113The number of shares in which you are interested has increased because:
any other event (you must briefly describe the relevant event in the Supplementary Information box)
 
 
2101Beneficial owner
 
926,155  HKD      0.1000 
3101Cash
 
Short position 
 
 
 
           
 
25. Total shares in listed corporation immediately before the relevant event:
 Total number of sharesPercentage figure (%)
Long position3,150,6000.64
 
26. Total shares in listed corporation immediately after the relevant event:
 Total number of sharesPercentage figure (%)
Long position4,076,7550.30
 
27. Capacity in which interests disclosed in Box 26 are held:
Code describing capacityNumber of shares
2101Beneficial owner
Long position4,076,755
 
28. Further information in derivative interests in listed corporation :
Derivatives code Exercise period (dd/mm/yyyy) Consideration - if derivatives granted by listed corporation Number of shares
  BeginsEndsCurrencyPrice for grantCurrencyExercise priceCurrencyPrice on assignment 
Long position
4106Unlisted derivatives - Cash settled
27/04/202025/04/2029HKD1HKD1.456HKD0.000370,975
 
29. Further information in relation to interests of children under 18 and/or spouse:
Child/SpouseName of child/spouseNumber of shares
 
 
30. Further information in relation to interests of corporations controlled by Director:
Name of controlled corporationAddress and place of incorporationName of controlling person% controlDirect interest (Y/N)Number of shares
   
 
31. Further information in relation to interests held by Director jointly with another person:
Name of joint shareholderAddressNumber of shares
 
 
32. Further information from a director who is a trustee, or beneficiary of a trust, or a person who has set up a Discretionary Trust:
Names of TrustAddressStatus codeNumber of shares
  
 
33. Further information from a party to an agreement under Section 317 (Please see Notes for further information required):
Names of other partiesAddressNumber of shares
 
Total number of shares in which a director is interested under sections 317 and 318
 
34. Supplementary information: Following the completion of the Rights Issue and the Subscriptions on 6 October 2025, the number of shares held by the director was increased and details of derivative interest was changed whereas the precentage of the interest in the shares was reduced. Please refer to the annonucement dated 6 October 2025 for the details of the Rights Issue and the Subscription and the annonucement dated 3 October 2025 for the details of adjustment to share options.
35. Log/Serial Number of the previous form:
36. Number of concert party document(s) under section 317 attached/uploaded:
Date of filing this Form 3A: 10/10/2025
(dd/mm/yyyy)